Open AccessImpact of COVID 19 Pandemic Crisis on the Health System and Pharmaceutical Industry
Author(s) -
Samah Hamed Almurisi,
Doaa Al Khalidi,
Khater Ahmed Saeed AL-Japairai,
Syed Uzair Mahmood,
Chaitanya Reddy Chilakamarry,
Chandra Babu Naidu Kadiyala,
Keithanchali Mohananaidu
Publication year - 2020
Publication title -
letters in applied nanobioscience
Language(s) - English
Resource type - Journals
ISSN - 2284-6808
DOI - 10.33263/lianbs102.22982308
Subject(s) - pandemic , covid-19 , business , pharmaceutical industry , health care , healthcare system , order (exchange) , economic growth , medicine , economics , finance , pharmacology , infectious disease (medical specialty) , disease , pathology
The magnitude of the COVID-19 pandemic has an enormous impact on the health system and pharmaceutical industry in almost every country globally. Health services have been disrupted at many dimensions globally; communicating with patients at homes away from clinics was commonly practiced in order to provide safety actions to the healthcare team. These measures affected the economic income of the hospitals in addition to health insurers as well. Additionally, drug makers' inability to get active pharmaceutical ingredients from Chinese factories was considered another challenge in this situation. The severe interruption of trading and traveling worldwide has resulted in a harmful impact on the real economy. Treatment of coronavirus infection was taken place by different protocols and based on the already existing medications. Most countries race to the rapid development of a vaccine.